Published in Anticancer Res on July 01, 2012
Non-viral nanocarriers for siRNA delivery in breast cancer. J Control Release (2014) 0.83
Rational design of cationic lipids for siRNA delivery. Nat Biotechnol (2010) 4.97
Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci U S A (2010) 4.25
Cationic liposome-mediated transfection. Nature (1989) 3.46
A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun (1991) 2.72
Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol Ther (2000) 2.34
Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles. Biochim Biophys Acta (1990) 1.50
Physical and biological properties of cationic triesters of phosphatidylcholine. Biophys J (1999) 1.34
The design of cationic lipids for gene delivery. Curr Pharm Des (2005) 1.09
O-ethylphosphatidylcholine: A metabolizable cationic phospholipid which is a serum-compatible DNA transfection agent. J Pharm Sci (1999) 1.08
Cationic transfection lipids. Curr Med Chem (2003) 1.00
New strategy for transfection: mixtures of medium-chain and long-chain cationic lipids synergistically enhance transfection. Gene Ther (2004) 0.97
Association of albumin or protamine to lipoplexes: enhancement of transfection and resistance to serum. J Gene Med (2004) 0.95
Hydrophobic moiety of cationic lipids strongly modulates their transfection activity. Mol Pharm (2009) 0.93
Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA. Biochim Biophys Acta (2006) 0.92
Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC. Gene Ther (1997) 0.87
Modulation of a membrane lipid lamellar-nonlamellar phase transition by cationic lipids: a measure for transfection efficiency. Biochim Biophys Acta (2008) 0.87
Evaluation of the antitumoral effect mediated by IL-12 and HSV-tk genes when delivered by a novel lipid-based system. Biochim Biophys Acta (2007) 0.86
Aerosol delivery of lipid:DNA complexes to lungs of rhesus monkeys. Pharm Res (1998) 0.85
Cationic lipids in gene delivery: principles, vector design and therapeutical applications. Curr Pharm Des (2002) 0.84
Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomes. J Control Release (2007) 0.83
Prospects for synthetic self-assembling systems in gene delivery. J Gene Med (2000) 0.81
Use of perfluorocarbon (fluorinert) to enhance reporter gene expression following intratracheal instillation into the lungs of Balb/c mice: implications for nebulized delivery of plasmids. J Pharm Sci (2001) 0.78
Cationic lipids: molecular structure/ transfection activity relationships and interactions with biomembranes. Top Curr Chem (2010) 0.78
Refractive error and ethnicity in children. Arch Ophthalmol (2003) 3.50
Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell (2012) 2.01
Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med (2010) 1.66
Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses. Cancer Res (2007) 1.60
Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. J Clin Endocrinol Metab (2005) 1.56
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood (2007) 1.51
Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J Control Release (2006) 1.45
Reconsidering the length of program accreditation. Am J Pharm Educ (2011) 1.44
Bitter and sweet taste receptors regulate human upper respiratory innate immunity. J Clin Invest (2014) 1.42
Survival and recurrence in nonmycosis fungoides primary cutaneous lymphoma. Cancer J (2009) 1.38
Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2. Mol Pharm (2009) 1.37
Targeted drug delivery via folate receptors. Expert Opin Drug Deliv (2008) 1.33
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clin Cancer Res (2013) 1.30
Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. J Pharm Pharm Sci (2007) 1.27
Targeted delivery systems for oligonucleotide therapeutics. AAPS J (2009) 1.19
Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition. J Med Chem (2006) 1.19
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents. Clin Cancer Res (2008) 1.17
Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit of an ion channel that mediates extracellular Ca2+ regulation of neuronal excitability. Proc Natl Acad Sci U S A (2012) 1.16
Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis (2003) 1.16
A hyperspectral imaging system for in vivo optical diagnostics. Hyperspectral imaging basic principles, instrumental systems, and applications of biomedical interest. IEEE Eng Med Biol Mag (2004) 1.16
Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor. Mol Cancer Ther (2008) 1.15
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer. Mol Ther Nucleic Acids (2013) 1.14
Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm (2007) 1.14
Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells. Mol Pharmacol (2005) 1.13
Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. J Clin Endocrinol Metab (2003) 1.12
Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor. Mol Pharmacol (2006) 1.12
Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv Drug Deliv Rev (2004) 1.12
Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes. J Pharm Sci (2007) 1.11
Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol (2010) 1.11
Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion (2004) 1.08
The final catalytic step of cytochrome p450 aromatase: a density functional theory study. J Am Chem Soc (2005) 1.08
Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. J Control Release (2004) 1.08
Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells. J Steroid Biochem Mol Biol (2002) 1.05
A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care (2011) 1.04
A folate receptor-targeted liposomal formulation for paclitaxel. Int J Pharm (2006) 1.03
Tumour-selective drug delivery via folate receptor-targeted liposomes. Expert Opin Drug Deliv (2004) 1.03
Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J Control Release (2002) 1.02
Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing. J Control Release (2009) 1.02
Imaging receptor-mediated endocytosis with a polymeric nanoparticle-based coherent anti-stokes Raman scattering probe. J Phys Chem B (2007) 1.01
Interleukin-17A induces bicarbonate secretion in normal human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol (2008) 1.01
Genetics of the taste receptor T2R38 correlates with chronic rhinosinusitis necessitating surgical intervention. Int Forum Allergy Rhinol (2013) 1.00
The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery. Int Forum Allergy Rhinol (2013) 1.00
Are we producing innovators and leaders or change resisters and followers? Am J Pharm Educ (2012) 1.00
Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer. J Steroid Biochem Mol Biol (2005) 0.99
Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer. Anticancer Agents Med Chem (2006) 0.99
Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter? Oncologist (2008) 0.99
Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy. Bioconjug Chem (2003) 0.98
Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells. Int J Pharm (2010) 0.97
Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery. Int J Pharm (2010) 0.97
Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pharm Res (2003) 0.97
Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy. Anticancer Agents Med Chem (2006) 0.97
Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells. Int J Pharm (2007) 0.97
Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma. Int J Nanomedicine (2012) 0.96
The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway. Anticancer Res (2004) 0.96
Nanoparticles as image enhancing agents for ultrasonography. Phys Med Biol (2006) 0.95
Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Transfusion (2012) 0.95
Folate receptor-mediated targeting of liposomal drugs to cancer cells. Methods Enzymol (2004) 0.95
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor. Nanomedicine (2013) 0.95
Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells. Mol Pharm (2007) 0.95
Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma. J Control Release (2013) 0.94
Aromatase and COX in breast cancer: enzyme inhibitors and beyond. J Steroid Biochem Mol Biol (2007) 0.94
Function analysis of estrogenically regulated protein tyrosine phosphatase gamma (PTPgamma) in human breast cancer cell line MCF-7. Oncogene (2004) 0.94
Transfection activity of binary mixtures of cationic o-substituted phosphatidylcholine derivatives: the hydrophobic core strongly modulates physical properties and DNA delivery efficacy. Biophys J (2006) 0.93
DNA release from lipoplexes by anionic lipids: correlation with lipid mesomorphism, interfacial curvature, and membrane fusion. Biophys J (2004) 0.93
Lipid nanoparticles for hepatic delivery of small interfering RNA. Biomaterials (2012) 0.93
Synthesis and biological evaluation of novel sulfonanilide compounds as antiproliferative agents for breast cancer. J Comb Chem (2008) 0.93
The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer. Anticancer Res (2002) 0.93
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells. Blood (2010) 0.92
A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug. Pharm Res (2004) 0.92
Clinical translation of folate receptor-targeted therapeutics. Expert Opin Drug Deliv (2012) 0.92
Comparison of increased aromatase versus ERα in the generation of mammary hyperplasia and cancer. Cancer Res (2011) 0.92
Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR. Bioconjug Chem (2007) 0.92
Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med (2005) 0.91
AMPK supports growth in Drosophila by regulating muscle activity and nutrient uptake in the gut. Dev Biol (2010) 0.91
A novel pH-sensitive liposome formulation containing oleyl alcohol. Biochim Biophys Acta (2002) 0.91
Targeted nanoparticles enhanced flow electroporation of antisense oligonucleotides in leukemia cells. Biosens Bioelectron (2010) 0.90
Synthesis and biological evaluation of selective aromatase expression regulators in breast cancer cells. J Med Chem (2007) 0.90
Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT). Bioconjug Chem (2006) 0.90
Synthesis of transferrin (Tf) conjugated liposomes via Staudinger ligation. Int J Pharm (2010) 0.90
Biodiversity and human livelihood crises in the Malay Archipelago. Conserv Biol (2006) 0.90
Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs. Pharm Res (2014) 0.90
Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease. Blood (2013) 0.90
Folate receptor targeted delivery of liposomal daunorubicin into tumor cells. Anticancer Res (2002) 0.89
Incorporation of reversibly cross-linked polyplexes into LPDII vectors for gene delivery. Bioconjug Chem (2002) 0.89
A facile microfluidic method for production of liposomes. Anticancer Res (2008) 0.88
Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats. PLoS One (2012) 0.88
Microfluidic methods for production of liposomes. Methods Enzymol (2009) 0.88
Cationic lipid-coated magnetic nanoparticles associated with transferrin for gene delivery. Int J Pharm (2008) 0.88
Antitumor activity of G3139 lipid nanoparticles (LNPs). Mol Pharm (2009) 0.88
SPANosomes as delivery vehicles for small interfering RNA (siRNA). Mol Pharm (2011) 0.88
Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations. J Control Release (2013) 0.88